AMICUS THERAPEUTICS, INC. — Board/Management Information 2015

Apr 13, 2015

*UNITED STATES SECURITIES AND EXCHANGE COMMISSION*

*Washington, D.C. 20549*

*FORM 8-K*

*CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934*

Date of Report (Date of earliest event reported): April 9, 2015

*AMICUS THERAPEUTICS, INC.*

(Exact name of registrant as specified in its charter)

Delaware	001-33497	71-0869350
(State or other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

1 Cedar Brook Drive, Cranbury, NJ	08512
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s telephone number, including area code: (609) 662-2000

(Former name or former address if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

SEQ.=1,FOLIO='',FILE='C:\JMS\C901915\15-9044-1\task7333802\9044-1-ba.htm',USER='C901915',CD='Apr 13 19:55 2015'

*Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.*

On April 9, 2015, James N. Topper, M.D., Ph.D. informed the board of directors (the “Board”) of Amicus Therapeutics, Inc. (the “Company”) that he will not seek re-election to the Board when his term expires at the Company’s upcoming 2015 Annual Meeting of Stockholders. Dr. Topper’s decision to not seek re-election did not result from any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\C901915\15-9044-1\task7333802\9044-1-ba.htm',USER='C901915',CD='Apr 13 19:55 2015'

*SIGNATURES*

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

AMICUS THERAPEUTICS, INC. — By:	/s/ WILLIAM D. BAIRD III
Name:	William D. Baird III
Title:	Chief Financial Officer

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\C901915\15-9044-1\task7333802\9044-1-ba.htm',USER='C901915',CD='Apr 13 19:55 2015'